A partial list of anticancer drugs based on increased ROS production
Drug (name) | Cancer treated | Mechanism to increase ROS | References |
---|---|---|---|
Platinum drugs | Breast cancer (in combination with PARP inhibitors) | ROS-dependent DNA damage | [8, 9] |
Imatinib | Melanoma | Loss of mitochondrial membrane potential | [10] |
Doxorubicin | Kaposi’s sarcoma, breast, and bladder cancer | Fenton’s reaction and electron leakage | [11] |
5-Fluorouracil | Colon and rectal cancer | P53 dependent ROS | [12, 13] |
PARP: poly (ADP-ribose) polymerase
RS: Conceptualization, Supervision. IGC: Supervision. PG: Conceptualization, Data curation, Formal analysis, Writing—original draft, Writing—review & editing. All authors read and approved the submitted version.
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2023.